Pharmaceutical Benefits Pricing Authority Policies, Procedures and Methods

Please note, this document is no longer current due to the cessation of the Pharmaceutical Benefits Pricing Authority on 1 April 2014. Further information regarding PBS pricing can be found under Pricing of PBS items.

The purpose of this document was to enhance the transparency of the processes employed by the Pharmaceutical Benefits Pricing Authority in recommending prices for pharmaceuticals to the Minister. This document clarified methods and procedures used by the Pricing Authority when recommending the listing price of new drugs and in the review of prices of existing drugs on the Pharmaceutical Benefits Scheme.

 

Page last modified: 20 January 2015